Vigna, E
Comoglio, P M
Article History
Received: 18 February 2014
Revised: 22 April 2014
Accepted: 22 April 2014
First Online: 2 June 2014
Competing interests
: PMC and EV are authors of the international patent WO2007090807 (‘Anti-met monoclonal antibody, fragments and vectors thereof …’) owned by Metheresis Translational Research SA (Switzerland); The University of Torino received financial support from Metheresis and PMC is a consultant. The company did not interfere at all in the preparation and in the submission of the review article.